METHOD FOR GENERATING NK CELLS

METHOD FOR REPROGRAMMING HUMAN SOMATIC CELLS INTO INDUCED PLURIPOTENT STEM CELLS

PREPARATION METHOD FOR ADENOVIRUS P53-LOADED DENDRITIC CELL VACCINE

SURF4 GENE KNOCKOUT ERYTHROID PROGENITOR CELLS AND METHODS OF ERYTHROID DIFFERENTIATION THEREOF

UT2 GENE KNOCKOUT ERYTHROID PROGENITOR CELLS AND METHODS OF ERYTHROID DIFFERENTIATION THEREOF

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

BIOMATERIALS AND PROCESSES FOR IMMUNE SYNAPSE MODULATION OF HYPOIMMUNOGENICITY

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

NATURAL KILLER CELLS

PROCESS FOR T CELL EXPANSION

COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY

CELL

PRODUCTION OF IMMUNE CELLS

B CELL LINEAGES DERIVED FROM PLURIPOTENT CELLS

MYELOID LINEAGES DERIVED FROM PLURIPOTENT CELLS

NATURAL KILLER CELL LINEAGES DERIVED FROM PLURIPOTENT CELLS

USE OF MEMORY LYMPHOCYTE POPULATION IN LIVER CANCER TREATMENT

ENGINEERED REGULATORY T CELLS

PROCESS FOR THE OBTENTION OF INVARIANT NATURAL KILLER T CELLS

CANCER-KILLING CELLS

METHOD OF PRODUCING VDELTA1+ T CELLS

CELLS DIFFERENTIATED FROM IMMUNOENGINEERED PLURIPOTENT CELLS

NUCLEATED CELL DEATH INDUCTION METHOD USING LOW TEMPERATURE TREATMENT

METHOD AND KIT FOR PREPARING AN IMMUNE CELL DIFFERENTIATED FROM A STEM CELL

NATURAL KILLER CELLS EXPRESSING DUAL-TARGETING CHIMERIC ANTIGEN RECEPTORS FOR CD19 AND CD22, PRODUCTION METHOD AND USES THEREOF

METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION

INITIALIZATION AGENT AND KIT FOR INITIALIZING BLOOD CELLS DERIVED FROM PERIPHERAL BLOOD, AND METHOD FOR INITIALIZING THE SAME

METHODS AND COMPOSITIONS USING RECOMBINANT DENDRITIC CELLS FOR CANCER THERAPY

ENGINEERED INVARIANT NATURAL KILLER T (INKT) CELLS AND METHODS OF MAKING AND USING THEREOF

USE OF LACTOFERRIN FOR GENERATING MYELOID-DERIVED SUPPRESSOR CELLS

REPROGRAMMING OF SOMATIC CELLS

METHOD FOR DIFFERENTIATING HEMATOPOIETIC STEM/PROGENITOR CELLS INTO NK CELLS

MODIFIED IMMUNE CELLS FOR TREATING AND/OR PREVENTING METASTASIS

USE OF HISTONE MODIFIERS TO REPROGRAM EFFECTOR T CELLS

LINEAGE SPECIFICATION DURING STEM CELL TRANSITION

Mononuclear Cell Derived NK Cells

METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF

Gammadelta T Cell Expansion Procedure

MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO

METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF

Thymic Epithelial Cells, Exosomes Derived Therefrom, and Methods of Making and Using Same

METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS

METHOD FOR PRODUCING MACROPHAGES, DIFFERENTIATION INDUCING AGENT, DIFFERENTIATION INDUCTION KIT, METHOD FOR CULTURING MACROPHAGES, AGENT FOR PROMOTING MACROPHAGE PROPAGATION, KIT FOR PROMOTING MACROPHAGE PROLIFERATION, METHOD FOR MACROPHAGE PROLIFERATION, AND MACROPHAGES

T CELL PROGENITOR HAVING CONTROLLED EXPRESSION OF A TRANSGENE OF INTEREST

ESTABLISHMENT OF ERYTHROID PRECURSOR CELL LINE CAPABLE OF CONDITIONAL MATURATION USING GENE OVEREXPRESSION

METHODS FOR TREATING OR PREVENTING VIRAL INFECTION

METHODS OF PREPARING T CELLS FOR T CELL THERAPY

CD34+CD41DIM MEGAKARYOCYTES PROGENITORS AND USES THEREOF FOR PRODUCING PROPLATELET-BEARING MKS AND/OR PLATELETS

DIFFERENTIATION AND USE OF HUMAN MICROGLIA-LIKE CELLS FROM PLURIPOTENT STEM CELLS AND HEMATOPOIETIC PROGENITORS

SUPERCENTENARIAN INDUCED PLURIPOTENT STEM (sciPS) CELLS AND METHODS OF MAKING AND USING THEREOF

MANUFACTURING METHOD OF MEMORY T CELLS

METHODS AND COMPOSITIONS FOR INDUCING FETAL HEMOGLOBIN, MODULATING ERYTHROID CELL LINEAGES, AND PERTURBING MEGAKARYOCYTE LINEAGES

METHODS FOR REPROGRAMMING CELLS AND USES THEREOF

METHOD OF GENERATING iPS CELL AND iPS CELL GENERATION SYSTEM

METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA

METHODS FOR THE EXPANSION OF HUMAN GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THERAPEUTIC PROTEINS

NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES

INDUCER FOR REPROGRAMMING T CELL INTO NK-LIKE CELL AND APPLICATION OF INDUCER

ENGINEERING STEM CELLS FOR ALLOGENIC CAR T CELL THERAPIES

CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY

GENERATING T CELL PRECURSORS VIA AGONIZING TUMOR NECROSIS FACTOR RECEPTOR 2

GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD

METHODS FOR EXPANDING HEMATOPOIETIC STEM CELLS USING REVITALIZED MESENCHYMAL STEM CELLS

COMPOSITIONS AND METHODS FOR DIFFERENTIATING AND EXPANDING B LINEAGE CELLS

METHODS FOR OBTAINING INDUCED PLURIPOTENT STEM CELLS

CANCER-KILLING CELLS

REPROGRAMMING OF CELLS AND USES THEREOF

NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS

CGMP COMPLIANT PRODUCTION AND EXPANSION OF PLASMACYTOID DENDRITIC CELLS FROM HEMATOPOIETIC STEM AND PROGENITOR CELLS

Human Cross-Presenting CD141+CLEC9A+ Dendritic Cells, Methods of Producing the Same from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells and Methods of Use

METHOD FOR PRODUCING OLIGODENDROCYTES

TRANSPLANTED CELL PROTECTION VIA Fc SEQUESTRATION

METHODS TO CONVERT SOMATIC HUMAN CELL TO A TOTIPOTENCY-LIKE STATE WITH ENGINEERED SOX17

GENETICALLY ENGINEERED ERYTHROCYTES CARRYING ANTI-PD-1 SINGLE CHAIN ANTIBODY AND PREPARATION METHOD THEREFOR

Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells

IMPROVED REPROGRAMMING, MAINTENANCE AND PRESERVATION FOR INDUCED PLURIPOTENT STEM CELLS

Method for Producing Stem Cell Clones Suitable for Induction of Differentiation into Somatic Cells

MODULATING BHLHE40 IN THE DIFFERENTIATION OF TYPE 1 REGULATORY T CELLS AND CONTROLLING T CELL EXHAUSTION

MATERIALS AND METHODS FOR BIOENGINEERED IPSC POPULATIONS

MASS PROLIFERATION CULTURE METHOD OF NK CELLS

METHOD FOR INDUCING ANTIGEN-SPECIFIC T CELL AND USE THEREOF IN TREATING CANCER OR VIRUS INFECTION

IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells

COMPOSITIONS AND METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES FOR TREATING MYELOPROLIFERATIVE NEOPLASMS

PROCESS FOR PRODUCING CULTURED RED BLOOD CELLS

ENHANCEMENT OF ANTITUMOR EFFECT OF IMMUNE CHECKPOINT INHIBITOR THROUGH ADMINISTRATION OF INTESTINAL RUMINOCOCCACEAE BACTERIUM

CANCER-KILLING CELLS

NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING BLOOD TO INDUCED PLURIPOTENT STEM CELLS

METHODS AND COMPOSITIONS FOR GENERATING HEMATOPOIETIC CELLS

NATURAL KILLER CELLS

METHOD FOR IN VITRO PRODUCTION OF RED BLOOD CELLS

GAMMADELTA T CELL EXPANSION PROCEDURE

METHODS FOR NUCLEAR REPROGRAMMING USING SYNTHETIC TRANSCRIPTION FACTORS

METHODS FOR TREATING CANCER AND AUTOIMMUNE AND INFLAMMATORY DISEASES

METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION

METHOD FOR GENERATING T CELLS PROGENITORS

PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES

T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS

METHODS FOR REPROGRAMMING CELLS AND USES THEREOF

GENE-EDITED NATURAL KILLER CELLS

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION

METHOD FOR OBTAINING CAR-NK CELLS

CELLS FOR TREATING CANCER

IMMUNE CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELL

COMPOSITIONS AND METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES

METHODS AND COMPOSITIONS FOR GENERATING HUMAN ERYTHROID PROGENITOR CELLS

Compositions and methods related to megakaryocyte-derived extracellular vesicles

GENE-EDITED NATURAL KILLER CELLS

Compositions and methods for treating hemoglobinopathies

ENGINEERING STEM CELL T CELLS WITH MULTIPLE T CELL RECEPTORS

SERUM-FREE MEDIUM AND CULTURING METHOD SUITED FOR CULTURING BLOOD CELLS SUCH AS HUMAN HEMATOPOIETIC STEM CELLS

COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY

ENGINEERED IMMUNE KILLER CELL, PREPARATION METHOD THEREFOR AND USE THEREOF

METHODS FOR GENERATING HEMATOPOIETIC STEM CELLS

METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF

CAR T CELLS WITH ENHANCED METABOLIC FITNESS

METHOD OF GENERATION OF LYMPHO-MYELOID NICHES

NATURAL KILLER CELLS

MEDIA FORMULATIONS AND METHODS FOR PRODUCING PROGENITOR T CELLS

METHODS AND A KIT TO REPROGRAM SOMATIC CELLS

MICRORNAS ENRICHED IN MEGAKARYOCYTIC EXTRACELLULAR VESICLES AND USES THEREOF

Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof

Compositions and methods for treating hemoglobinopathies

METHOD FOR MEMORY B CELL-SPECIFIC DIFFERENTIATION INDUCTION, AND USES THEREOF

METHODS OF ENGINEERING PLATELETS FOR TARGETING CIRCULATING TUMOR CELLS

Method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonist

METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS BY REPROGRAMMING SOMATIC CELLS

ENGINEERED HUMAN IMMUNE CELLS, PREPARATION METHOD AND APPLICATION THEREOF

ERYTHROCYTE REMOVAL DEVICE, MONONUCLEAR CELL COLLECTOR, CELL CULTURE DEVICE, CELL CULTURE SYSTEM, CELL CULTURE METHOD, AND MONONUCLEAR CELL COLLECTION METHOD

METHODS FOR OBTAINING INDUCED PLURIPOTENT STEM CELLS

T CELL PRODUCTION FROM RAG INACTIVATED IPSCS

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

METHODS FOR CREATING INTEGRATION-FREE, VIRUS-FREE, EXOGENOUS ONCOGENE-FREE IPS CELLS AND COMPOSITIONS FOR USE IN SUCH METHODS

METHODS FOR GENERATION OF TUMOR ORGANOID-FISHED T CELLS AND IDENTIFICATION OF ANTI-TUMOR T CELL RECEPTORS

GABA AGONISTS AND ANTAGONISTS AFFECT DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS AND MEGAKARYOCYTE PROGENITORS

CELL CULTURE VESSEL AND METHOD FOR CULTURING CELL

MANUFACTURING ANTI-BCMA CAR T CELLS

METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF HEMOGLOBINOPATHY

Gene-edited natural killer cells

Gene-edited natural killer cells

MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO

MICROGLIAL PROGENITORS FOR REGENERATION OF FUNCTIONAL MICROGLIA IN THE CENTRAL NERVOUS SYSTEM AND THERAPEUTICS USES THEREOF

OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSE

COMPOSITIONS AND METHODS FOR MODULATING METABOLIC REGULATORS OF T CELL PATHOGENICITY

CD34+CD41DIM MEGAKARYOCYTES PROGENITORS AND USES THEREOF FOR PRODUCING PROPLATELET-BEARING MKS AND/OR PLATELETS

Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof

NATURAL KILLER CELLS

METHODS RELATING TO PLURIPOTENT CELLS

MEDIA AND METHODS FOR DIFFERENTIATING NATURAL KILLER CELLS

GENERATION OF FUNCTIONAL AND PATIENT-SPECIFIC THYMIC TISSUE IN VIVO FROM INDUCED PLURIPOTENT STEM CELLS

MOBILIZED PERIPHERAL BLOOD AS A SOURCE OF MODIFIED IMMUNE CELLS

METHODS OF MAKING PLATELETS COMPRISING MODIFIED RECEPTORS AND USES THEREOF

GENERATION AND CRYOPRESERVATION OF PLURIPOTENT STEM CELL-DERIVED CLINICAL GRADE CORNEAL ENDOTHELIAL CELLS

PRODUCTION METHODS FOR MEGAKARYOCYTES AND PLATELETS

IMPROVED T CELL MANUFACTURING PROCESS

Use of lactoferrin for generating myeloid-derived suppressor cells

ENGINEERED REGULATORY T CELLS

T Cells with Improved Mitochondrial Function

METHOD FOR PRODUCING ERYTHROID CELLS AND/OR ERYTHROCYTES

CD11B + PIEZO-1 + MACROPHAGES AND USES THEREOF

THERAPEUTIC CANCER VACCINES DERIVED FROM A NOVEL DENDRITIC CELL LINE

CELLS DIFFERENTIATED FROM IMMUNOENGINEERED PLURIPOTENT CELLS

METHODS OF OBTAINING A MIXED POPULATION OF HUMAN XCR1+ AND PLASMACYTOID DENDRITIC CELLS FROM HEMATOPOIETIC STEM CELLS

METHOD FOR PRODUCING MEMORY-LIKE NK CELLS WITH ABILITY TO EXPRESS HIGHER LEVELS OF NCRS, CYTOTOXICITY, AND IFN-y THAN NK CELLS IN HUMAN PERIPHERAL BLOOD

USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS

Platelet-derived mitochondria treatment and method of generating multipotent cells

FcyRIIIa signaling generates Bcl6+PD1+CD4+ Tfh-like cells

USE OF MEMORY LYMPHOCYTE POPULATION IN LIVER CANCER TREATMENT

Method for producing liver stem cells or liver progenitor cells by direct reprogramming

Cancer-killing cells

Use of histone modifiers to reprogram effector T cells

Mesenchymal stromal cells and uses related thereto

Method for generating T cell progenitors

Method for generating T cells progenitors

Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof

CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY

STEM-CELL DERIVED MYELOID CELLS, GENERATION AND USE THEREOF

METHOD FOR PRODUCING NATURAL KILLER CELLS

SOMATIC STEM CELLS

Supercentenarian induced pluripotent stem (sciPS) cells and methods of making and using thereof

HEMATOPOIETIC PROGENITOR CELL MARKER

CBL inhibitors and compositions for use in adoptive cell therapy

CBL INHIBITORS AND COMPOSITIONS FOR EXPANSION OF IMMUNE CELLS

strain and strain-derived polysaccharide

Method for Producing Stem Cell Clones Suitable for Induction of Differentiation into Somatic Cells

METHODS OF PREPARING T CELLS FOR T CELL THERAPY

IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells

Method for reconstructing immune function using pluripotent stem cells

Methods for allogenic hematopoietic stem cell transplantation

Methods for directed differentiation of pluripotent stem cells to immune cells

Methods for allogenic hematopoietic stem cell transplantation

Mononuclear cell derived NK cells

Mononuclear cell derived NK cells

Engineered regulatory T cells

METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS

METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Method for obtaining T cells from pluripotent stem cells, and uses thereof

Method for differentiation of human pluripotent stem cell lines in suspension culture

Method for generating T cells progenitors

Methods for nuclear reprogramming using synthetic transcription factors

Methods for nuclear reprogramming of cells

Method for reprogramming blood to induced pluripotent stem cells

NATURAL KILLER CELLS AND USES THEREOF

METHODS OF MAKING, EXPANDING, AND USING A HUMAN PROGENITOR T CELL

METHOD FOR PREPARING ANTIGEN-SPECIFIC REGULATORY T CELLS

Thymic epithelial cells, exosomes derived therefrom, and methods of making and using same

GAMMA DELTA T CELLS AND USES THEREOF

Methods and compositions for inducing hematopoietic cell differentiation

Pharmaceutical Composition for Preventing or Treating Autoimmune Disease, and Method for Producing Same

DIFFERENTIATION AND USE OF HUMAN MICROGLIA-LIKE CELLS FROM PLURIPOTENT STEM CELLS AND HEMATOPOIETIC PROGENITORS

INTERFERON PRIMED PLASMACYTOID DENDRITIC CELLS

Methods of preparing T cells for T cell therapy

METHODS OF REPROGRAMMING ANIMAL SOMATIC CELLS

T Cell Expansion Method

A SUBSTRATE AND METHOD FOR THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS

Methods for expanding hematopoietic stem cells using revitalized mesenchymal stem cells

GAMMADELTA T CELL EXPANSION PROCEDURE

NOVEL METHODS FOR THE GENERATION AND USE OF HUMAN INDUCED NEURAL BORDER STEM CELLS

HAR-NDS-DERIVED STEM CELLS, METHOD FOR SEPARATING SAME, AND USE THEREOF

γδ T cell expansion procedure

Antigen-specific immune effector cells

Genomic engineering of pluripotent cells

COMPOSITION COMPRISING GLYCYRRHIZIN FOR INDUCING DIFFERENTIATION INTO MYELOID-DERIVED SUPPRESSOR CELL FROM MYELOID CELL

In vitro production of red blood cells with proteins comprising sortase recognition motifs

IL-23R ANTAGONISTS TO REPROGRAM INTRATUMORAL T REGULATORY CELLS INTO EFFECTOR CELLS

Methods and compositions for generating hematopoietic cells

METHOD FOR GENERATING T CELLS PROGENITORS

Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides

Methods for production of platelets from pluripotent stem cells and compositions thereof

Method For Producing Induced Pluripotent Stem Cells

Natural killer cells

PERFUSION DEVICE AND PERFUSION METHOD

System and Method to Generate Progenitor Cells

Methods and Compositions for Producing Germ Cells from Bone Marrow Derived Germline Stem Cells

Method for inducing differentiated cell into Mesenchymal Stem Cell, and combinations of regulatory targets thereof

Production of megakaryoctye compositions and therapies for treatment of thrombocytopenia

METHODS OF GENERATING NATURAL KILLER CELLS

Methods for creating integration-free, virus-free, exogenous oncogene-free IPS cells and compositions for use in such methods

Cancer-killing cells

Method of making induced pluripotent stem cells using p53 inhibitors

Methods and Compositions for Producing Germ Cells from Peripheral Blood Derived Germline Stem Cells

Genomic engineering of pluripotent cells

METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION

Immune cells derived from induced pluripotent stem cell

Detection of CD5 and methods and compositions for modulating CD5

Induced pluripotent stem cells produced from dendritic cells

COMPOSITIONS, SYSTEMS AND METHODS FOR PROGRAMMING IMMUNE CELL FUNCTION THROUGH TARGETED GENE REGULATION

Efficient method for reprogramming blood to induced pluripotent stem cells

MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO

Composition for promoting maturation of dendritic cell containing fusion protein of Rv2299c and ESAT-6

Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells

Efficient method for reprogramming blood to induced pluripotent stem cells

Cellular Reprogramming Utilizing mRNA

Process for T cell expansion

Methods for reprogramming cells and uses thereof

Platelet production promoter and method of producing platelets using same

Methods for reprogramming cells and uses thereof

Pharmaceutical composition for preventing or treating regulatory T cell-mediated diseases

Therapeutic cancer vaccines derived from a novel dendritic cell line

Method for regenerating T cells and applications thereof

Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using

Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes

MODIFIED CELLS FOR PRODUCTION OF BLOOD CELLS

PROCESS OF GENE-EDITING OF CELLS ISOLATED FROM A SUBJECT SUFFERING FROM A METABOLIC DISEASE AFFECTING THE ERYTHROID LINEAGE, CELLS OBTAINED BY SAID PROCESS AND USES THEREOF

Methods for production of platelets from pluripotent stem cells and compositions thereof

Methods for directed differentiation of pluripotent stem cells to immune cells

Means and methods for generating midbrain organoids

Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins

In vitro production of red blood cells with sortaggable proteins

METHODS FOR IN VITRO PRODUCTION OF PLATELETS AND COMPOSITIONS AND USES THEREOF

Improved method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonist

CD34CD41megakaryocytes progenitors and uses thereof for producing proplatelet-bearing MKs and/or platelets

Method for generating T-cell progenitors

Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response

Generating mature lineages from induced pluripotent stem cells with MECP2 disruption

METHOD FOR IN VITRO EXPANSION OF ERYTHROID CELLS

GENERATING INDUCED NEURAL PROGENITOR CELLS FROM BLOOD

ANTI-INFLAMMATORY AGENTS

MODIFIED CELLS FOR PRODUCTION OF BLOOD CELLS

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION

Method for Producing Stem Cell Clones Suitable for Induction of Differentiation into Somatic Cells

METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS

METHOD FOR MASS PRODUCING NATURAL KILLER CELL AND USE OF NATURAL KILLER CELL OBTAINED BY THE METHOD AS ANTI-CANCER AGENT

Methods for production of platelets from pluripotent stem cells and compositions thereof

Efficient method for reprogramming blood to induced pluripotent stem cells

Reprogramming of somatic cells

Gammadelta T cell expansion procedure

CD11 B[low] MACROPHAGES AND CONDITIONED MEDIA THEREOF FOR TREATING CANCER AND/OR FIBROSIS

Mammalian alveolar macrophages derived from pluripotent cells

Method for induction of T cells from pluripotent stem cells

Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof

MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO

Reprogramming T cells and hematopoietic cells

Methods and Vectors to Produce Vector Free Induced Pluripotent Stem Cells

Use of PDL1 expressing cells to convert T cells into regulatory T cells

Cancer vaccines and vaccination methods

HAR-NDS-derived stem cells, method for separating same, and use thereof

Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells